STOCK Tg(ACTB-Neurog3)1Bzal/Orl

Status	Available to order
EMMA ID	EM:01100
Citation information	RRID:IMSR_EM:01100 Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.
International strain name	STOCK Tg(ACTB-Neurog3)1Bzal/Orl
Alternative name	beta-actin-floxed-ngn3
Strain type	Transgenic Strains
Allele/Transgene symbol	Tg(ACTB-Neurog3)1Bzal
Gene/Transgene symbol	Tg(ACTB-Neurog3)1Bzal

Information from provider

Provider	Bernard Zalc
Provider affiliation	INSERM U561 - Hopital Saint Vincent de Paul, Paris
Phenotypic information	None.
References	None available

Information from EMMA

Archiving centre	CNRS-TAAM – Typing and Archiving of Animal Models, Orléans, France

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

Frozen embryos. Delivered in 4 weeks (after paperwork in place). €1740^*
Rederivation of mice from frozen stock, delivery time available upon request . €3880^*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

^* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
For this strain no provider MTA is needed. Distribution is based on the EMMA conditions only.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.
Not found what you were looking for? Search here for other strains available from EMMA.